The transfer of nuclei of fully differentiated cells into enucleated oocytes is a well-recognized method for the generation of embryonic stem (ES) cells. Here, we demonstrate that nuclear transferred ES (NT-ES) cells can be established with high efficiency using innate-like B lymphocytes as donor cells. We established two mouse lines carrying rearranged immunoglobulin heavy and light chains using NT-ES cells containing nuclei from peritoneal cavity B1 cells. Analysis of B1 clone lines revealed that the B1-cell generation critically depends on the interaction between antigen (possibly self-antigen) and surface immunoglobulin, while the B1-cell maintenance requires the peritoneal environment. The B1-cell expansion takes place in spleen, and is held in check by competitor B2 cells. The results indicate that the NT-ES method could replace the transgenic or knock-in mouse approaches currently used to study the biology of cells that undergo somatic rearrangements of their antigen receptor genes.
Introduction
The establishment of mouse lines carrying rearranged BCRs and TCRs has provided a powerful tool to analyze the development of lymphocytes in vivo (1, 2) . The availability of mice with a monoclonal population with a naive phenotype was instrumental for the studies of lymphocyte differentiation into functionally distinct subsets. Indeed, the first studies on lymphocyte activation were performed with defined antigen(s) and mice expressing transgenic receptor(s) specific for the antigen(s) (3) (4) (5) (6) (7) . However, the generation of mice carrying lymphocyte antigen receptor genes requires the establishment of lymphocyte clones or hybridomas, the identification and cloning of receptor genes and the construction of transgenic or knock-in vectors, steps that are extremely labor intensive and time consuming (8) (9) (10) (11) (12) (13) (14) (15) . Moreover, it is difficult, if not impossible, to apply this method to lymphocyte populations that cannot be cultured and maintained for further characterization in vitro.
It has been demonstrated that cloned mice can be established directly by nuclear transfer from adult somatic cells into enucleated oocytes (16, 17) . However, the efficiency of generating such mice was extremely low and essentially no clones could be obtained from inbred mouse strains (18, 19) . More recently, embryonic stem (ES) cells were established using the nuclear transfer technique (20) . The ES lines that contain lymphocyte-derived nuclei can be used to generate chimeras and mouse lines carrying the receptor genes of the original lymphocyte (21) . These mouse lines should be similar to the BCR or TCR knock-in mice for the organization of rearranged receptor genes. This method requires no in vitro manipulation and as such, even lymphocytes that are difficult to culture can serve as nuclear donors. However, here again, the low efficiency of the establishment of nuclear transferred ES (NT-ES) cells using lymphocytes as donors has hampered the use of this method for immunology research. By modifying our initial protocol for the production of cloned mice, we succeeded to increase (~10-fold) the efficiency for the establishment of NT-ES cells (22) (23) (24) . The modified system allowed us to establish large numbers of NT-ES cells using different lymphocyte subpopulations.
A lymphocyte population involved in protection against primary infections is represented by innate-like memory B1 cells (25) . This particular B-cell subset, along with the splenic marginal zone B cells, makes the optimal transition between early innate and adaptive immune responses (25, 26) . B1 cells contribute significantly to IgM antibodies present in the serum of nonimmunized mice, known as natural antibodies. These polyreactive antibodies, which bind to foreign antigens as well as to self-antigens, are critical for host survival from bacterial and viral infections (25, (27) (28) (29) .
B1 cells express high levels of surface IgM and low levels of B220, IgD or CD23. A fraction of B1 cells that express CD5 are known as B1a cells, while the remaining CD5 low/− B1 cells are designated as B1b (30) . Unlike conventional B2 cells, which have a limited life span and are constantly replenished from the bone marrow (BM) progenitors, most B1 cells develop in the neonate from fetal liver progenitors and survive thereafter by self-replenishment (30, 31) . Spleen (SPL) is apparently required for the homeostatic proliferation and maintenance of B1 cells (32) . The generation and survival of B1 cells require BCR-mediated signals from their environment (33) (34) (35) . However, still relatively little is known about the molecular signals required for the B1-cell development, selection, activation and survival (25, 36, 37) .
We sought to generate the tools that would allow the study of specificity and the biology of individual B1 cells. Thus, we generated mouse lines carrying immunoglobulin genes from B1 cells. We present here the initial characterization of two B1 cell lines, one expressing a typical BCR composed on nonmutated V H 11 that preferentially associates with Igκ, the other bearing a noncanonical BCR with a V H that has significant N additions and paired with Igλ chain.
Methods

Mice
C57BL/6, B10.D2/n, Balb/c and DBA/2 mice were purchased from Clea Japan (Tokyo, Japan). Immunoglobulin J segmentdeficient mice on the Balb/c background (J H −/− ) and RAG1 −/− (both on C57BL/6 and Balb/c backgrounds) were originally purchased from the Jackson Laboratory. Fluorescent ubiquitination-based cell cycle indicator (Fucci) Azami Green (AG) transgenic mice (31) were backcrossed seven times to C57BL/6 mice. All mice were maintained under specific pathogen-free conditions in the animal facility of RIKEN Research Center for Allergy and Immunology. All animal experiments were performed in accordance with approved protocols from the Institutional Animal Care at RIKEN.
Establishment of NT-ES cell lines and chimera mice
Nuclear transfer, oocyte activation and ES cell establishment were carried out according to the methods described previously (22) . Briefly, embryos at the morula stage were treated with acid Tyrode's solution to remove the zona pellucida and placed in 96-well dishes with mouse embryonic fibroblasts [Imprinting Control Region (ICR) origin] for >10 days in CultiCell media. Proliferating cells were dissociated by trypsin digestion and replated on fibroblasts until stable cell lines grew out. All established NT-ES cells were tested by alkaline phosphatase staining, immunostaining for Oct3/4 and Nanog, and karyotyping using Spectral Karyotype technique-fluorescence in situ hybridization (FISH) staining according to the manufacturer's protocol (Spectral Imaging Ltd, Vista, CA, USA). For the establishment of chimeras, NT-ES cells were injected into Balb/c blastocysts.
Flow cytometry analysis and cell sorting
The following mAbs were purchased from eBiosciences except goat anti-mouse IgM (Southern Biotech): anti-B220 (RA3-6B2), anti-IgM (AF6-78), anti-CD5 (53-7.3), anti-κ light (L) chain (187.1) and anti-λ L chain (R26-46). For staining, cells were washed with staining buffer (Dulbecco's PBS supplemented with 2% FCS and 0.02% sodium azide) and stained with a combination of antibodies for 15 min on ice in the same buffer. In some experiments, cells were stained in the presence of anti-FcR (2.4G2) mAbs to reduce background of Fc binding of antibodies. 7-Amino-actinomycin D (BD Pharmingen) was added to the samples to gate out dead cells. Samples were analyzed on a FACS Calibur (Becton Dickinson) with CellQuest or FlowJo software. To purify IgM + and CD5 + B1 cells, cells washed out of the peritoneal cavity (PerC) of F1 mice between C57BL/6 and B10D2 strains were stained with PE-anti-CD5 antibodies and FITCanti-IgM antibodies and sorted with a MoFlo (Cytomation) cell sorter. Stainings were carried out multiple times (at least >3 times for each experiment) using at least three mice for each experiment and representative results are shown in this report.
Serum immunoglobulin ELISA
Serum immunoglobulin concentrations were determined by IgG or IgM ELISA quantitation set (Bethyl).
Detection and sequencing of immunoglobulin genes
Mononuclear cells were separated from peripheral blood lymphocytes (PBL) and SPL of indicated mouse lines using FicollPaque PLUS (Amersham Biosciences) and total RNA from the indicated cell populations was used to synthesize cDNA using a Superscript II kit (Invitrogen). Reverse transcription (RT)-PCR to amplify the IgM heavy (H) chain was performed according to the methods described previously (38) . For λ L chain sequencing, specific primer sets (Supplementary Table 1 , available at International Immunology Online) were used to amplify all three λ chains (39) . Amplified products were cloned into pGEM-T easy (Promega) and sequenced. PCR primers were then designed for the detection of genomic DNA containing rearranged H and L chains Supplementary Figure 1 , available at International Immunology Online) and used for the screening of mice. 
Transfer of CFSE-labeled B cells
Results
Establishment of mouse line from ES cells carrying B1-cell nuclei
PerC cells from B10D2 × C57BL/6J F1 mice were stained with anti-IgM and anti-CD5 antibodies and cells expressing both markers (B1a cells, hereafter called B1 cells) were sorted (Fig. 1A) . ES cells were established by injecting B1-cell nuclei into enucleated oocytes. A total of 198 activated oocytes that received the B1-cell nuclei were cultured according to a previously established method (20) . Forty-six cells reached blastocyst stage and finally, 12 ES cell lines were established (6.1% success rate).
Two ES cell lines (Lym14 and Lym21) were injected into Balb/c blastocysts to produce chimeras. Chimeras with >95% ES cell-derived coat color were used for the initial analysis. In the peripheral blood of both Lym14 and Lym21 chimeras, a vast majority of IgM + B cells was found to express CD5, suggesting preferential development of B1 cells from ES cells. Interestingly, the B cells in both chimera lines expressed the λ L chain but not the κ chain ( 
Analysis of mice carrying Lym14 B1-cell-derived immunoglobulin genes
Chimeras were mated with C57BL/6 mice and the offspring were tested for the presence of ES cell-derived immunoglobulin H and L chains by PCR. Both the H and L chains were transmitted in a Mendelian fashion, indicating that the nuclear transfer to establish ES cell lines using lymphocytes as nuclear donors is an efficient method to generate mouse lines with rearranged immunoglobulin genes.
In Lym14 mice expressing both the immunoglobulin H and L chains (H + L + mice), a vast majority of B cells present in PBL expressed IgM and CD5, and thus were B1 cells ( Fig. 2A) . Surprisingly, all IgM + CD5 + B1 cells expressed both the immunoglobulin κ and λ L-chains, indicating the lack of isotypic exclusion ( Fig Thus, Lym14 mice develop B1 cells with the typical V H 11-Vκ association of the immunoglobulin genes.
Analysis of mice carrying Lym21 B1-cell-derived immunoglobulin genes
In the PBL of Lym21 mice that express both the immunoglobulin H and L chains (H + L + ), the majority of B cells was IgM + CD5 + B220 low B1 cells (Fig. 3A) . In contrast to Lym14 mice, the vast majority of these B1 cells expressed the original Igλ chain, indicating relatively strict isotypic exclusion in the Lym21 mouse line (Fig. 3A, red histograms) . Indeed, regardless of the tissues tested, >80% of the B1 cells expressed Igλ, while the rest of the cells expressed both Igλ and κ chains ( Fig. 3B and C) . The frequencies and total numbers of B1 cells were extremely high in the PerC (>10 7 B1 cells) and SPL (>10 9 B1 cells) of Lym21 H + L + mice. In the peripheral LN or MLN, although the total numbers of B1 cells were higher than in WT mice, their frequencies were very much reduced compared with PerC, SPL or PBL, indicating a tissue-specific accumulation of Lym21 B1 cells ( (Fig. 3C ). Taken together, the Lym14 V H 11 associates preferentially with the immunoglobulin κ L-chain, while the Lym21 H chain predominantly uses the immunoglobulin λ L-chain to generate B1 cells. Both Lym14 and Lym21 B1 cells can be found abundantly into the peripheral blood and SPL and localize preferentially into PerC.
Effect of background genes on the development of B1 cells expressing Lym21 immunoglobulin gene
In order to analyze the role of the Lym21 H chain in the development of B1 cells in the absence of endogenous immunoglobulin H-chain expression, C57BL/6 mice carrying Lym21 H and L chain genes were mated with mice lacking the H chain J segments (J H −/− ) on the Balb/c background (42) . Initial analysis of F1 mice showed no differences between Lym21 H chain/J H WT and Lym21 H chain/J H -deficient mice, indicating very little, if any, effect of the presence of endogenous immunoglobulin H chain on the phenotype. However, after three generations of backcrossing to Balb/c J H −/− mice, we found several different phenotypes in the offsprings (Fig. 4, left panels) .
All Lym21 H 
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chain were analyzed for the presence of B1 cells. As shown in Fig. 4 (Fig. 4, right lower  panel) . It should be mentioned that the same mice mated with Balb/c J H −/− mice did not produce any offsprings with an increased number of B1 cells, even though the Lym21 H chain was transmitted in a Mendelian fashion (data not shown). These results demonstrate that in mice carrying the Lym21 H chain alone, the development of B1 cells likely requires C57BL/6-derived gene product(s). Alternatively, but not mutually exclusively, the differences in the cytokine milieu between the C57BL/6 and Balb/c mice may result in differential B1-cell expansion. We are currently attempting to establish a Balb/c congenic mouse line carrying C57BL/6-derived gene(s) responsible for the development of B1 cells with the Lym21 H chain. 
Immunoglobulin L chain usage in B1 cells expressing Lym21 H chain
The usage of the immunoglobulin L chain in B1 cells sorted from mice carrying the Lym21 H chain alone was analyzed. Thus, B1 cells were sorted on the basis of the expression of CD5 from the mice containing both B1 and B2 cells and the L chain usage was analyzed by semiquantitative PCR using primer pairs specific for Vλ1, Vλ2 and VλX (Supplementary Table 1 , available at International Immunology Online). As shown in Fig. 5A , although the amount of PCR product for each chain was different, all three Vλ chains were amplified from the B1 cells. However, when these Vλ chain products were sequenced, a significant number of Vλ1 and VλX genes were nonfunctionally rearranged (Fig. 5B) . By contrast, all Vλ2 genes were functionally rearranged and, 22 out of 30 were identical to the λ chain of the original Lym21 B1 cells (Fig. 5C) . Five Vλ2 chain genes had a single nucleotide difference with no amino acid change, two had one amino acid substitution with the same single nucleotide difference, and one Vλ2 gene had two amino acid substitutions. 
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at International Immunology Online, lower panel), the Vλ2 gene products were amplified and sequenced using RNA samples from the total spleen-cell population. All Vλ2 gene products were functionally rearranged. Thirteen out of 15 Vλ2 genes were identical to the Lym21 L chain and the other two Vλ2 genes had two independent nucleotide changes with no amino acid sequence difference from the original Lym21 L chain (Fig. 5C) . These results strongly indicate that in both C57BL/6 and Balb/c backgrounds, the H chain preferentially associates with certain λ chains but the generation of B1 cells requires yet undefined gene(s) or the cytokine milieu and other environmental factors present in the C57BL/6 background.
Proliferation of B1 cells expressing Lym21 immunoglobulin genes
To test the role of proliferation for the generation and maintenance of B1 cells bearing Lym21 immunoglobulin genes, B cells from the Lym21 H + L + mice (on the C57BL/6 background) were labeled with CFSE and transferred intravenously to RAG1-deficient or sufficient C57BL/6 mice. The proliferation of B1 cells in the SPL and PerC was analyzed 4 days after the transfer. As shown in Fig. 6A , B1 cells exhibited extensive cell cycle progression in RAG1 −/− mice. Cells transferred into WT mice showed drastically less cell cycle progression, indicating limited B1-cell proliferation in the presence of competitor lymphocytes. When the same experiment was carried out using B1 cells from Lym21 mice on the Balb/c background (mice were backcrossed to nine generations), the magnitude of B1-cell proliferation in Balb/c RAG1 −/− mice was greatly diminished compared with that in C57BL/6 mice. In normal Balb/c mice, transferred B1 cells showed very little, if any, proliferation (Fig. 6A, lower panels) . It should be noted that the absolute number of B1 cells from Lym21 H + L + mice was similar in both the C57BL/6 and Balb/c backgrounds (~10 9 cells per When C57BL/6 RAG1 −/− mice that received Lym21 B1 cells were monitored for an extended period, the number of B1 cells in the SPL was found to gradually increase up to day 7 and to decrease thereafter. In contrast, the number of B1 cells in the PerC continued to increase up to day 24 after cell transfer (Fig. 6B ). These results demonstrate that the B1 cells proliferate for a limited time mainly in the SPL but their long-term survival seems to require their relocation to the PerC.
To further investigate the proliferation of Lym21 B1 cells in vivo, we crossed Lym21 H + L + mice with mice carrying the transgene for a cell cycle indicator (Fucci mice on a C57BL/6 background). Fucci mice express AG-human Geminin fusion protein that is under cell cycle-dependent ubiquitination control and detected as AG fluorescence only in the S/G2/M phase of 
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the cell cycle (43) . As shown in Fig. 6C , in mice carrying Lym21 H and L chains and Fucci transgene, ~6% of the B1 cells present in the SPL and BM were in the S/G2/M phases of the cell cycle. It should be noted that these B1 cells were proliferating in the SPL where >5 × 10 8 B1 cells were present, ruling out the possibility of lymphopenia-driven proliferation of B1 cells. In contrast, very few AG + B1 cells were detected in the PerC. Our findings indicating that Lym21 B1 cells proliferate mainly in the SPL and BM but not in the PerC are consistent with previous reports that the activation and proliferation of WT B1 cells occur in the SPL but their long-term survival is dependent on the PerC environment (32, (44) (45) (46) .
Discussion
In this study, we have demonstrated that NT-ES cells can be used for the analysis of lymphocyte development in vivo. The transfer of peritoneal B1-cell nuclei into oocytes following conventional methods for ES cell establishment yielded 12 independent ES cell lines. One full day for nuclear transfer and 30 days of daily maintenance of cells were required to establish the ES cell lines. Thus, the efficiency of ES cell establishment from B1 cells is sufficiently high to enable its use for the analysis of a large number of mouse lines carrying different immunoglobulin genes. We have tested a large variety of cell types for the establishment of NT-ES cells that include regulatory T cells, tissue-infiltrating T cells from pancreas and IgA plasma cells from the gut (Supplementary  Table 2 , available at International Immunology Online) and overall, 2-6% of activated oocytes become ES cell lines. Thus, given the capacity to carry out 300 injections per day, it is possible to establish a sufficient number of ES cell lines from any type of lymphocytes of interest for the production of chimeras and germline transmitted mouse lines.
We chose to make mice using B1 cells as the nuclear donors for the following reasons. Several immunoglobulin gene transgenic and knock-in mouse lines were previously generated to study B1-cell development and biology in vivo (10, 34, 38, (47) (48) (49) . However, those immunoglobulin genes were obtained from either B1-like tumor cells or from hybridomas derived from B1 cells with conventional molecular genetic techniques. Those strategies are time consuming and labor intensive and the results obtained from different mouse lines generated are as yet not fully compatible. Thus, in order to establish mouse lines with monoclonal B1-cell populations with greater ease, we tested the possibility of using ES cells carrying B1-cell nuclei.
Here we presented the initial characterization of two lines of ES cells derived from B1-cell nuclear transfer. In chimeras derived from Lym14 and Lym21 ES cell lines, all B cells of the ES origin were exclusively of the B220 low   IgM   +   CD5 + phenotype, indicating that ES cells contain the B1-cell-derived genome. Furthermore, both chimeras successfully transmitted immunoglobulin genes to offspring in a Mendelian fashion, allowing the establishment of mouse lines carrying B1-cellderived immunoglobulin genes. Considering the time required for the establishment of ES cells (~1 month) and the number of ES cell lines obtained in our experiments (12 lines), our approach is significantly more effective than the previously used transgenic/knock-in approach for the study of B1-cell biology. It should also be noted that, unlike knock-in mice in which the rearranged immunoglobulin gene is inserted into the immunoglobulin locus, NT-ES mice contain the rearranged immunoglobulin genes generated by physiological gene rearrangement. Thus, NT-ES mice would provide a better system to study secondary events occurring in the locus, such as immunoglobulin gene editing and V H replacement.
Lym14 B1 cells contained one functionally rearranged V H 11 Ig gene with no N addition known to be used by B1 cells (40, 50) and one functional λ L chain gene. As expected, B1 cells in the chimeras expressed λ L chains associating with V H 11. However, upon mating with normal mice, B1 cells containing the Lym14 H chain alone preferentially used κ L chain(s). Interestingly, even in the mice carrying Lym14 H and L chains (H + L + ), a vast majority of the B1 cells expressed both endogenous κ and the original Lym14 λ chains. These results are in complete agreement with the previous report that B1 cells with the V H 11 H chain prefer the κ L chain (50), thus confirming the validity of our approach using NT-ES cells for the study of lymphocyte development.
The second line of ES cells, Lym21, also generated B1 cells with several unique features. The Lym21 immunoglobulin H chain (V H 7183.19.36) contained significant N additions at the VDJ junction. This H chain associated with a particular λ L chain for the generation of B1 cells. In the mouse carrying the Lym21 H chain alone (H + L − ), the B2 cells used the κ L chain, suggesting that there is no structural constraint for the Lym21 H chain to associate with different L chains. However, the λ L chains used for B1 cells were very uniform for their amino acid sequence with more nucleotide differences, suggesting that the selection of the λ L chain is based on antigen specificity determined by a combination of H and L chains.
Interestingly, Lym21 H + L + B1 cells expanded vigorously in vivo, and accumulated mainly in SPL and PerC or BM, and much less in other peripheral lymphoid organs. The apparent exclusion of B1 cells from the peripheral lymphoid organs usually inhabited by conventional B2 cell and T cells is very intriguing, and the mechanisms responsible for this segregation (i.e. homing, survival, cell death due to under or overstimulation of the BCR) remain to be determined in the future. Analysis of cell cycle progression in vivo with Fucci transgene clearly demonstrated that Lym21 B1 cells proliferated mainly in the SPL and BM but their survival depended on the environment of the PerC, thus extending the results obtained in previous studies with normal B1 cells (37, 44, 46, 50) .
In the mouse carrying Lym21 H chain alone, the development of B1 cells seemed to be dependent on as yet un identified, C57BL/6 genetic element(s). Indeed, even though Lym21 H + L − mice with the Balb/c background contained few B cells expressing endogenous L chain identical to the Lym21 L chain, they failed to generate a significant B1-cell population. However, in the absence of competitor B2 cells, i.e. H + L + mice, Lym21 B1 cells proliferate extensively even in the Balb/c background. A similar pattern of B1-cell proliferation was also observed in the transfer experiments where the magnitude of proliferation differed significantly between lymphopenic and normal recipients, as well as between C57BL/6 and Balb/c backgrounds. In lymphopenic RAG1 −/− mice, the transferred B1 cells proliferated well and the magnitude of proliferation was significantly higher in C57BL/6 than in Balb/c recipients (Fig. 6A) . In contrast, transferred Lym21 H + L + B1 cells exhibited a limited proliferative capacity in normal C57BL/6 mice but no proliferation at all in Balb/c mice.
Taken together, our results indicate that the interaction between surface immunoglobulin and endogenous antigen(s) plays a critical role in the development and maintenance of B1 cells. We speculate that in Balb/c mice, the presence of competitor B2 cells, combined with weak interaction with selfantigen(s) (or less antigen) do not allow the proliferation of Lym21 B1 cells. These findings are compatible with the previous studies demonstrating that the development of B1 cells requires interaction of surface BCR with self-antigen, and that weak interaction with the antigen due to the low density of surface BCR abrogates B1-cell development (33, 34, 39) .
We attempted to characterize the molecule required for Lym21 B1-cell development in C57BL/6 mice, by staining SPL cells from RAG2 −/− mice on C57BL/6 and Balb/c backgrounds with serum from C57BL/6 Lym21 H + L + mice. However, the serum contained very limited amount of immunoglobulin in both Lym 14 and Lym 21 mouse lines and showed no significant staining of SPL cells (Supplementary Figure 5 , available at International Immunology Online). These results suggest the presence of down-regulatory mechanisms for immunoglobulin production in these mouse lines (Fig. 2C ) that did not allow characterization of endogenous antigen(s). Thus, we are currently focusing our attention on the establishment of a Balb/c congenic mouse line carrying C57BL/6 genetic element(s). The congenic mouse line is expected to be an important tool for identification of gene(s) and gene product(s) required for Lym21 B1-cell generation.
In summary, we confirmed and extended a previous report showing that ES cells could be established by nuclear transfer from B lymphocytes to generate mouse lines carrying re arranged immunoglobulin genes (21) . The modified method used in this study was very efficient as it allowed us to establish multiple mouse lines carrying immunoglobulin genes with no in vitro manipulations. We suggest that the nuclear transfer system to establish the ES cell line and the mouse line could replace the currently used TCR and BCR transgenic as well as the knock-in approaches to study the biology of B and T cells.
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